Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors
申请人:D'Orchymont Hugues
公开号:US20060004000A1
公开(公告)日:2006-01-05
Compound corresponding to general formula (I):
in which, R
1
represents a hydrogen or halogen atom, an NH
2
, NHR
2
, NHCOR
2
, NO
2
, CN, CH
2
NH
2
and CH
2
NHR
2
; or alternatively R
1
represents an optionally substituted phenyl or an optionally substituted heteroaromatic group;
Ar represents an optionally substituted phenyl group or an optionally substituted heteroaromatic group; n represents 0, 1, 2 or 3; in the form of a base, of an addition salt with an acid, of a hydrate or of a solvate. Application in therapy.
通用公式(I)对应的化合物:其中,R1代表氢原子或卤素原子,NH2,NHR2,NHCOR2,NO2,CN,CH2NH2和CH2NHR2;或者R1代表可选择取代的苯基或可选择取代的杂环芳基;Ar代表可选择取代的苯基或可选择取代的杂环芳基;n表示0、1、2或3;以碱、与酸的加合盐、水合物或溶剂化合物的形式。在治疗中的应用。